Search Results
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Trisha Dwight in
Google Scholar
PubMed
Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark
Search for other papers by Aidan Flynn in
Google Scholar
PubMed
Search for other papers by Kaushalya Amarasinghe in
Google Scholar
PubMed
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Diana E Benn in
Google Scholar
PubMed
Search for other papers by Richard Lupat in
Google Scholar
PubMed
Search for other papers by Jason Li in
Google Scholar
PubMed
Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Daniel L Cameron in
Google Scholar
PubMed
Search for other papers by Annette Hogg in
Google Scholar
PubMed
Search for other papers by Shiva Balachander in
Google Scholar
PubMed
The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Ida L M Candiloro in
Google Scholar
PubMed
Search for other papers by Stephen Q Wong in
Google Scholar
PubMed
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Bruce G Robinson in
Google Scholar
PubMed
Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
The Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Anthony T Papenfuss in
Google Scholar
PubMed
Cancer Diagnosis and Pathology Group, Kolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Anthony J Gill in
Google Scholar
PubMed
The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia
Search for other papers by Alexander Dobrovic in
Google Scholar
PubMed
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Rodney J Hicks in
Google Scholar
PubMed
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Richard W Tothill in
Google Scholar
PubMed
( Tischler et al . 2017 ). Activation of TERT as a result of promoter mutations (specifically, chr5:1295228C > T and chr5:1295250C > T) were initially found in melanoma ( Horn et al . 2013 ) and have subsequently been shown to be one of the most
Search for other papers by Johan O Paulsson in
Google Scholar
PubMed
Search for other papers by Ninni Mu in
Google Scholar
PubMed
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Ivan Shabo in
Google Scholar
PubMed
Search for other papers by Na Wang in
Google Scholar
PubMed
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Introduction The telomerase enzyme consists of a protein component with reverse transcriptase activity, encoded by the telomerase reverse transcriptase ( TERT ) gene ( Cong et al. 2002 ). Telomerase activation is a hallmark of malignant
Search for other papers by Tiantian Liu in
Google Scholar
PubMed
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Search for other papers by Taylor C Brown in
Google Scholar
PubMed
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Search for other papers by Adam Andreasson in
Google Scholar
PubMed
Search for other papers by Na Wang in
Google Scholar
PubMed
Search for other papers by Martin Bäckdahl in
Google Scholar
PubMed
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Search for other papers by James M Healy in
Google Scholar
PubMed
Search for other papers by Manju L Prasad in
Google Scholar
PubMed
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Search for other papers by Reju Korah in
Google Scholar
PubMed
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Search for other papers by Tobias Carling in
Google Scholar
PubMed
Search for other papers by Dawei Xu in
Google Scholar
PubMed
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
telomerase reverse transcriptase (TERT), a catalytic subunit of the telomerase enzyme complex. As the de-repression of TERT gene transcription is intimately coupled with the acquisition of telomerase activity in transformed cells, regulatory mechanisms
Search for other papers by Matthias S Dettmer in
Google Scholar
PubMed
Search for other papers by Anja Schmitt in
Google Scholar
PubMed
Search for other papers by Hans Steinert in
Google Scholar
PubMed
Search for other papers by David Capper in
Google Scholar
PubMed
Search for other papers by Holger Moch in
Google Scholar
PubMed
Search for other papers by Paul Komminoth in
Google Scholar
PubMed
Search for other papers by Aurel Perren in
Google Scholar
PubMed
transcriptase ( TERT ) gene, which encodes for the catalytic subunit of telomerase, is implicated in tumorigenesis and cell immortalization. The two promoter mutations C228T and C250T were recently reported in human melanomas and other human cancer types
Medical School, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
Search for other papers by Vicente Rodrigues Marczyk in
Google Scholar
PubMed
Medical School, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
Medical School, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
Medical School, Universidade do Vale do Rio dos Sinos (UNISINOS), Brazil
Search for other papers by Iuri Martin Goemann in
Google Scholar
PubMed
Introduction The catalytic subunit of the telomerase enzyme is encoded by the telomerase reverse transcriptase ( TERT ) gene and is crucial for telomerase activity. Two hotspot mutations affecting the promoter region of TERT were discovered
Search for other papers by Soomin Ahn in
Google Scholar
PubMed
Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed
Search for other papers by Sun Wook Kim in
Google Scholar
PubMed
Search for other papers by Chang Seok Ki in
Google Scholar
PubMed
Search for other papers by Hye Won Jang in
Google Scholar
PubMed
Search for other papers by Jee Soo Kim in
Google Scholar
PubMed
Search for other papers by Jung Han Kim in
Google Scholar
PubMed
Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed
Search for other papers by Jung Hee Shin in
Google Scholar
PubMed
Search for other papers by Soo Yeon Hahn in
Google Scholar
PubMed
Search for other papers by Young Lyun Oh in
Google Scholar
PubMed
Search for other papers by Jae Hoon Chung in
Google Scholar
PubMed
frequency of PD-L1 expression in various thyroid cancers and the relationship between PD-L1 expression and clinicopathologic factors including BRAF , TERT promoter status and disease progression were evaluated. Materials and methods Case
Search for other papers by Rengyun Liu in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
Introduction Telomerase reverse transcriptase in human cancer Telomerase reverse transcriptase (TERT) is the catalytic protein subunit of telomerase, which, together with an integral RNA subunit and several species-specific assessor proteins
Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea
Search for other papers by Young Shin Song in
Google Scholar
PubMed
Search for other papers by Seong-Keun Yoo in
Google Scholar
PubMed
Search for other papers by Hwan Hee Kim in
Google Scholar
PubMed
Search for other papers by Gyeongseo Jung in
Google Scholar
PubMed
Search for other papers by Ah-Reum Oh in
Google Scholar
PubMed
Search for other papers by Ji-Young Cha in
Google Scholar
PubMed
Search for other papers by Su-jin Kim in
Google Scholar
PubMed
Search for other papers by Sun Wook Cho in
Google Scholar
PubMed
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Kyu Eun Lee in
Google Scholar
PubMed
Search for other papers by Jeong-Sun Seo in
Google Scholar
PubMed
Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea
Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Introduction Telomerase reverse transcriptase ( TERT ) has a canonical role maintaining telomere length and the nontelomeric function, which can regulate the expression of various genes involved in cell proliferation and cellular signaling
Search for other papers by Rengyun Liu in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
required to achieve this. Two recently discovered mutations in the promoter of the gene for telomerase reverse transcriptase (TERT) in thyroid cancer show promise in this regard – chr5:1 295 228C>T and chr5:1 295 250C>T (termed herein as C228T and C250T
Search for other papers by Xiaoli Liu in
Google Scholar
PubMed
Search for other papers by Justin Bishop in
Google Scholar
PubMed
Search for other papers by Yuan Shan in
Google Scholar
PubMed
Search for other papers by Sara Pai in
Google Scholar
PubMed
Search for other papers by Dingxie Liu in
Google Scholar
PubMed
Search for other papers by Avaniyapuram Kannan Murugan in
Google Scholar
PubMed
Search for other papers by Hui Sun in
Google Scholar
PubMed
Search for other papers by Adel K El-Naggar in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
telomerase reverse transcriptase (TERT). Promoter mutations in the TERT gene on chromosome 5 have recently been reported in melanomas ( Horn et al . 2013 , Huang et al . 2013 ). Two TERT promoter mutations, 1 295 228 C>T and 1 295 250 C>T (termed C228T